How is Aerobic Exercise Compared to Localized Pain Relief Exercises in Patients With Jaw Pain and Neck Pain?
Launched by HOCHSCHULE OSNABRUCK · Jan 26, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two different types of exercise on patients who have chronic jaw and neck pain. Specifically, it compares local neck exercises that focus on controlling neck muscles with aerobic exercises like cycling. Both types of exercise aim to reduce pain and improve daily functioning for people suffering from conditions like temporomandibular disorder (jaw pain) and neck pain.
To participate, women aged 18 to 60 who have had pain in their neck or jaw for at least three months and score moderate to severe pain on a specific scale may be eligible. Participants will be randomly assigned to one of the two exercise groups for a 12-week program and will complete assessments at various points to track their progress. This study is important not only for understanding how these exercises might help with pain relief but also for gathering data that could lead to further research and funding in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Be between 18-60 years of age
- • Be diagnosed with idiopathic chronic neck pain as described the IASP and/or presence of temporomandibular disorders identified by DC/TMD screening
- • Have pain in the neck or jaw area for at least 3 months (chronic pain)
- • Have pain not attributable to recent acute trauma, previous infection, or to an active inflammatory cause in the last month
- • Have a moderate or severe baseline pain score of 30mm or greater using a 100mm VAS
- Exclusion Criteria:
- • Present red flags for serious pathologies related to neck pain or jaw pain
- • Report comorbidity functional chronic pain disorders (e.g., fibromyalgia)
- • Have been diagnosed with psychiatric disorders (e.g., depression, schizophrenia)
- • Have received therapy within 3 months prior to entry into the study
About Hochschule Osnabruck
Hochschule Osnabrück, a renowned higher education institution in Germany, is dedicated to advancing scientific research and innovation through its clinical trial initiatives. With a strong focus on interdisciplinary collaboration and practical application, the university engages in pioneering studies aimed at enhancing healthcare outcomes. By leveraging its extensive network of academic experts and state-of-the-art facilities, Hochschule Osnabrück is committed to conducting high-quality clinical trials that contribute to medical knowledge and improve patient care. The institution prioritizes ethical standards and regulatory compliance, ensuring that all research activities uphold the highest levels of integrity and accountability.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Osnabrück, Niedersachsen, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials